NCT03781128View on ClinicalTrials.gov

Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cluster Headache
Interventions
DRUG

Lysergic Acid Diethylamide

100 µg, per os, 3 times within 3 weeks

DRUG

Placebo

placebo in an identical-looking vial as LSD, per os, 3 times within 3 weeks

Trial Locations (1)

4031

RECRUITING

Clinical Pharmacology & Toxicology, University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER